Save information for later
Sign Up

Learn About NUT Carcinoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top NUT Carcinoma Local Doctors?
Advanced in NUT Carcinoma
Pediatric Hematology Oncology | Hematology | Oncology
Advanced in NUT Carcinoma
Pediatric Hematology Oncology | Hematology | Oncology
161 Fort Washington Ave, Ip-7, 
New York, NY 
 (190.0 mi)
Languages Spoken:
English

Filemon Dela-Cruz is a Pediatric Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Dela-Cruz and is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. His top areas of expertise are Adult Soft Tissue Sarcoma, NUT Carcinoma, Osteosarcoma, and Ewing Sarcoma.

Advanced in NUT Carcinoma
Pediatric Hematology Oncology | Pediatrics | Hematology
Advanced in NUT Carcinoma
Pediatric Hematology Oncology | Pediatrics | Hematology

Memorial Pediatric Group

1275 York Ave, 
New York, NY 
 (193.9 mi)
Languages Spoken:
English

Neerav Shukla is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in New York, New York. Dr. Shukla and is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. His top areas of expertise are Ewing Sarcoma, Leukemia, Adult Soft Tissue Sarcoma, Osteosarcoma, and Bone Marrow Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in NUT Carcinoma
Pediatric Hematology Oncology | Pediatrics
Advanced in NUT Carcinoma
Pediatric Hematology Oncology | Pediatrics

Memorial Pediatric Group

1275 York Ave, 
New York, NY 
 (193.9 mi)
Languages Spoken:
English

Ira Dunkel is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in New York, New York. Dr. Dunkel and is rated as an Advanced provider by MediFind in the treatment of NUT Carcinoma. His top areas of expertise are Retinoblastoma, Gliomatosis Cerebri, Diffuse Midline Glioma H3 K27M-Mutant, and Brain Stem Cancer.

What are the latest NUT Carcinoma Clinical Trials?
A Phase 1 Study of BET Bromodomain Inhibitor ZEN003694 in Combination With the CDK4/6 Inhibitor Abemaciclib in Patients With NUT Carcinoma, Breast Cancer and Other Solid Tumors

Summary: This phase I trial tests the safety, side effects, and best dose of a ZEN003694 when given together with abemaciclib in treating patients with NUT carcinoma, breast cancer or other solid tumors that have spread from where it first started (primary site) to other places in the body (metastatic) or cannot be removed by surgery (unresectable). ZEN003694 is an inhibitor of a family of proteins called ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1 Study of EP31670, a Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Summary: A Phase 1, first-in-human study of EP31670, a dual BET and CBP/p300 inhibitor in patients with targeted advanced solid tumors and Hematological Malignancies